Video Shorts
0:54
AI's Recent Advancements in the Pharmaceutical Industry
5 months ago
by
Nicholas Jacobus(+1 more)
0:42
Fixing Drug Supply Chains
6 months ago
by
Mike Hollan(+1 more)
0:56
Approaching Inclusivity and Representation in the Development and Communication of Biomarker-Driven Diagnostics
6 months ago
by
Nicholas Jacobus(+1 more)
1:06
Understanding Volatility Over a 16-Quarter Presidency in Biopharma
6 months ago
by
Mike Hollan(+1 more)
0:57
Transforming Care from Discovery to Delivery
6 months ago
by
Chris Mazzolini
0:41
MJH Buys BPD: Expanding Reach to Clinicians, Patients
6 months ago
by
Chris Mazzolini
0:48
The Problems DTC Can Address
6 months ago
by
Mike Hollan(+1 more)
0:52
What Makes TrumpRx Unique
6 months ago
by
Mike Hollan(+1 more)
0:44
Looming DSCSA Enforcement
6 months ago
by
Nicholas Jacobus(+1 more)
0:53
Transitioning from COO to CEO
6 months ago
by
Mike Hollan(+1 more)
0:59
Obesity Medication's Unique Marketing Environment
6 months ago
by
Mike Hollan
1:06
AI at FDA
6 months ago
by
Mike Hollan
0:59
Preparing for Tariffs
6 months ago
by
Mike Hollan
0:34
Federated Data Networks
6 months ago
by
Mike Hollan
0:47
The Breakthrough of Multiomics
7 months ago
by
Mike Hollan
1:01
Regulatory Uncertainty
7 months ago
by
Mike Hollan
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
3
Positioning A New Standard of Care in Relapsed Multiple Myeloma: Q&A with Imran Khan, MD, PhD
4
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
5